Remove 2026 Remove Insurance Coverage Remove License
article thumbnail

Fundamental Analysis Of Sun Pharma – Financials & More Details

Trade Brains

trillion in value by 2026. Sun Pharma in-licensed and commercialised an anti-acne product in the US market. Let us move forward to read about the pharma industry landscape in the next section of our fundamental analysis of Sun Pharmaceutical Industries. annualised rate.